Publicacións (12) Publicacións de Enrique García Campo

2023

  1. Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?

    International Journal of Cardiology, Vol. 386, pp. 59-64

  2. Low rates of inappropriate shocks in contemporary real-world implantable cardioverter defibrillator patients: the CARAT observational study

    Europace, Vol. 25, Núm. 9

2022

  1. Effect of mitral regurgitation on stroke risk in patients with non-rheumatic atrial fibrillation

    Archives of Cardiovascular Diseases, Vol. 115, Núm. 8-9, pp. 448-456

2021

  1. Electrocardiographic evolution of interatrial conduction consistent with Bayés syndrome after transcatheter aortic valve implantation

    Journal of Interventional Cardiac Electrophysiology, Vol. 62, Núm. 3, pp. 605-606

  2. Pacemaker lead implantation in a patient with transcatheter bicaval prosthesis

    Europace

  3. Renin-Angiotensin System Inhibitors Prognostic Benefit in Older Patients with Atrial Fibrillation

    Journal of the American Medical Directors Association, Vol. 22, Núm. 10, pp. 2190-2195

2020

  1. Impact of anticoagulation in patients with dementia and atrial fibrillation. Results of the CardioCHUVI-FA registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 877-884

  2. Quality of life of patients undergoing conventional vs leadless pacemaker implantation: A multicenter observational study

    Journal of Cardiovascular Electrophysiology, Vol. 31, Núm. 1, pp. 330-336

2019

  1. Diagnosis-to-ablation time in atrial fibrillation: A modifiable factor relevant to clinical outcome

    Journal of Cardiovascular Electrophysiology, Vol. 30, Núm. 9, pp. 1483-1490

2018

  1. Left atrial geometry and outcome of atrial fibrillation ablation: Results from the multicentre LAGO-AF study

    European Heart Journal Cardiovascular Imaging, Vol. 19, Núm. 9, pp. 1002-1009

2017

  1. Association of cardiac resynchronization therapy with the incidence of appropriate implantable cardiac defibrillator therapies in ischaemic and non-ischaemic cardiomyopathy

    Europace, Vol. 19, Núm. 11, pp. 1818-1825

2016

  1. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies

    Journal of the American College of Cardiology, Vol. 68, Núm. 22, pp. 2440-2451